Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
$78.36
-0.9%
$76.42
$56.97
$84.46
$152.84B0.592.10 million shs1.20 million shs
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
$16.06
-4.7%
$0.00
$10.87
$18.79
$405.91MN/A108,178 shs49,934 shs
Starfighters Space, Inc. stock logo
FJET
Starfighters Space
$9.92
+13.4%
$6.04
$4.39
$31.50
$434.90MN/A1.73 million shs3.88 million shs
NUCL
Eagle Nuclear Energy
$10.03
+0.3%
$0.00
$4.55
$14.22
$295.62M0.19450,450 shs139,454 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
-1.65%-5.59%+4.64%+7.49%+12.06%
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
+0.06%+23.62%+1,684,999,900.00%+1,684,999,900.00%+1,684,999,900.00%
Starfighters Space, Inc. stock logo
FJET
Starfighters Space
+1.04%+31.63%+73.41%+31.03%+873,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
$78.36
-0.9%
$76.42
$56.97
$84.46
$152.84B0.592.10 million shs1.20 million shs
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
$16.06
-4.7%
$0.00
$10.87
$18.79
$405.91MN/A108,178 shs49,934 shs
Starfighters Space, Inc. stock logo
FJET
Starfighters Space
$9.92
+13.4%
$6.04
$4.39
$31.50
$434.90MN/A1.73 million shs3.88 million shs
NUCL
Eagle Nuclear Energy
$10.03
+0.3%
$0.00
$4.55
$14.22
$295.62M0.19450,450 shs139,454 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
-1.65%-5.59%+4.64%+7.49%+12.06%
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
+0.06%+23.62%+1,684,999,900.00%+1,684,999,900.00%+1,684,999,900.00%
Starfighters Space, Inc. stock logo
FJET
Starfighters Space
+1.04%+31.63%+73.41%+31.03%+873,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
2.73
Moderate Buy$93.4219.21% Upside
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
0.00
N/AN/AN/A
Starfighters Space, Inc. stock logo
FJET
Starfighters Space
0.00
N/AN/AN/A
NUCL
Eagle Nuclear Energy
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest FJET, BUD, CNXU, and NUCL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/1/2026
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
Reiterated RatingHold (C)
5/21/2026
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
Reiterated RatingBuy
5/19/2026
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
Reiterated RatingBuy
5/7/2026
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
Boost Price TargetOverweight$84.00 ➝ $93.83
5/7/2026
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
Reiterated RatingBuy
5/6/2026
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
Reiterated RatingBuy
5/6/2026
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
Reiterated RatingNeutral
5/6/2026
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
Reiterated RatingBuy
5/6/2026
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
Reiterated RatingBuy
5/6/2026
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
Boost Price TargetOverweight$88.00 ➝ $93.00
(Data available from 6/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
$59.32B2.58$6.51 per share12.03$50.11 per share1.56
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/AN/AN/AN/AN/AN/A
Starfighters Space, Inc. stock logo
FJET
Starfighters Space
N/AN/AN/AN/AN/AN/A
NUCL
Eagle Nuclear Energy
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
$6.84B$3.6621.4116.191.3011.90%12.26%5.39%7/30/2026 (Estimated)
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Starfighters Space, Inc. stock logo
FJET
Starfighters Space
N/AN/AN/AN/AN/AN/AN/AN/AN/A
NUCL
Eagle Nuclear Energy
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest FJET, BUD, CNXU, and NUCL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2026Q1 2026
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
$0.90$0.97+$0.07$1.30$14.69 billion$15.27 billion
3/31/2026Q1 2026
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
N/A$0.97N/A$1.30N/A$15.27 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
$1.411.80%+18.22%38.52%N/A
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/AN/AN/AN/AN/A
Starfighters Space, Inc. stock logo
FJET
Starfighters Space
N/AN/AN/AN/AN/A
NUCL
Eagle Nuclear Energy
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
0.74
0.72
0.57
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/AN/AN/A
Starfighters Space, Inc. stock logo
FJET
Starfighters Space
N/AN/AN/A
NUCL
Eagle Nuclear Energy
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
5.53%
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
N/A
Starfighters Space, Inc. stock logo
FJET
Starfighters Space
N/A
NUCL
Eagle Nuclear Energy
89.78%
CompanyEmployeesShares OutstandingFree FloatOptionable
Anheuser-Busch InBev SA/NV stock logo
BUD
Anheuser-Busch InBev SA/NV
136,8051.95 billion1.86 billionOptionable
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
425.27 millionN/AN/A
Starfighters Space, Inc. stock logo
FJET
Starfighters Space
N/A44.17 millionN/AN/A
NUCL
Eagle Nuclear Energy
N/A29.58 million29.23 millionN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Anheuser-Busch InBev SA/NV stock logo

Anheuser-Busch InBev SA/NV NYSE:BUD

$78.36 -0.68 (-0.86%)
As of 01:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Anheuser-Busch InBev SA/NV produces, distributes, exports, markets, and sells beer and beverages. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands. The company operates in North America, Middle America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The company was founded in 1366 and is headquartered in Leuven, Belgium.

Conexeu Sciences stock logo

Conexeu Sciences NASDAQ:CNXU

$16.06 -0.79 (-4.66%)
As of 01:51 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. --- Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property ("IP") developed over more than a decade at the University of British Columbia (the "University") and the BC Professional Firefighters Burn and Wound Healing Laboratory. In November 2023, the Company entered into a patent assignment agreement with the University pursuant to which the Company acquired an assignment of the University's right, title, and interest in the applicable patents and patent applications related to the underlying technology. The Company's only device candidate is the CXU™ scaffold device candidate, which is in preclinical development and has not been approved or cleared for marketing in any jurisdiction. The Company is conducting preclinical research and preparing for regulatory engagement to evaluate potential use in wound care and other medical applications. Any potential benefits to patients, providers, or healthcare systems have not been established and will require further study and regulatory review. CXU™ is a temperature-responsive, collagen-based extracellular matrix ("ECM") formulation designed to transition from a liquid to a gel-like scaffold following topical application or injection, typically within approximately ten minutes (the "10 Minute Tissue™" concept). The device IP is protected by issued and pending patents and is being evaluated in preclinical studies for its ability to provide an ECM-like environment associated with cellular infiltration, vascularization, and organized tissue remodeling in non-clinical models. We intend to seek U.S. Food and Drug Administration ("FDA") clearance in the United States for the CXU™ scaffold device candidate through the 510(k) premarket notification process as a Class II medical device; however, the FDA has not yet determined the appropriate classification or regulatory pathway for our device candidate, may require additional data or a different pathway, and there can be no assurance that we will obtain clearance or that the device candidate will become commercially available. Our principal executive offices are located in Reno, Nevada.

Starfighters Space stock logo

Starfighters Space NYSEAMERICAN:FJET

$9.91 +1.18 (+13.44%)
As of 01:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.

The Company's mission statement is to make space accessible to entrepreneurs, researchers, industry, and government at a high cadence and the right cost. Currently, Starfighters operates the world's only commercial fleet of flight-ready F-104 supersonic aircraft ("Lockheed F-104"). The Lockheed F-104 was developed as a supersonic aircraft for the United States Armed Forces. The single engine interceptor was favoured for its maximum altitude and climb performance. It was the first production aircraft to reach over MACH 2 in sustained, level flight, which was one of the key criteria as to why the NASA used the Lockheed F-104 for high-speed flight research at the Dryden Flight Research Center. The Lockheed F-104 also performed many safety chase missions in support of advanced research aircraft and provided a launch platform for sounding rockets(1). Test flights showed that a Lockheed F-104 launched single-stage Viper sounding rocket attain a maximum 112km in altitude(2). In total, the Lockheed F-104 flew over 18,000 missions for NASA. NASA retired the Lockheed F-104 in 1995(3), with transition to the McDonnell Douglas F/A-18 Hornet supersonic Aircraft(4). Recent increases in government expenditures and commercial investment are driving growth in the space economy(5). We believe this increase has created a demand for services similar to those that Lockheed F-104s formerly owned by the National Aeronautics and Space Administration ("NASA") used to provide. That demand is for commercial, research and defense technologies including hypersonic research(6). To the Company's knowledge, there is currently no other aircraft commercially available to the public with the capabilities of the Lockheed F-104 in terms of speed and climbing performance. The Company has built a consistent business by providing pilot and astronaut training and in-flight testing related services (the "Historical Services"), delivering over its history, solutions for defense, civil, academic and commercial uses, and expects to continue to serve a range of customers in the private and public sectors. Furthermore, we believe the increased demand for space access, particularly in lower earth orbits as well as the government and private sector's focus on hypersonic research and development combine to create new opportunities for Starfighters Space (the "New Services"). The Company aims to address these needs through its existing fleet of seven Lockheed F-104 Aircraft, currently based at NASA's Kennedy Space Center and Midland International Air & Space Port, as well as through the acquisition of the Platform II Aircraft which the Company believes will provide more advanced capabilities and have a longer operating lifespan. Starfighters is providing its core group of Historical Services, while developing the capacity for New Services. The Company organizes its services into the following categories: º Historical Services: º Pilot and Astronaut Training; º Launch Services and Access to Space; and º In-flight Testing. º New Services: º Launch Services and "Access to Space" (commercial, academic, civil and government clients); and º Airborne Testbed for Hypersonic Research and Development ("R&D") and Test and Evaluation ("T&E") Test Bed (commercial, academic, civil and government). (1) Jaroslaw Dobrzyński, Lockheed F-104 Starfighter, Yellow Series (Mushroom Model Publications, 2015). (2) F-104 Launched Sounding Rockets, The Unwanted Blog (Jun. 2, 2012), The Unwanted Blog. (3) F-104 Starfighter, NASA (Sept. 27, 2009), NASA. (4) Roy Bryant, The Lockheed F104s of NASAs Flight Research Center, Stars of NASA (Feb. 2004), Stars of NASA. (5) Space Foundation, The Space Report 2025 Q2 Highlights Record $613 Billion Global Space Economy for 2024, Driven by Strong Commercial Sector Growth (22 July 2025), online: . [https://perma.cc/V2HE-4EJT]. (6) U.S. Naval Institute Staff, Report to Congress on Hypersonic Weapons, U.S. Naval Institute (Feb. 16, 2024, 12:27 PM), U.S. Naval Institute. Starfighters Space, Inc. ("Starfighters") was founded and incorporated under the laws of the Delaware on September 6, 2022. The Company's goal is to make space accessible to entrepreneurs, researchers, industry participants, and the government at a high cadence and the right cost. The Company's head office and mailing address is located in Cape Canaveral, FL.

Eagle Nuclear Energy NASDAQ:NUCL

$10.02 +0.03 (+0.25%)
As of 01:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Eagle Nuclear Energy Corp. operates as a mining and exploration company focused on mineral exploration and development in North America. The company is a nuclear energy company that combines domestic uranium exploration with proprietary Small Modular Reactor (SMR) technology. It also develops modular nuclear reactors to provide power for industrial and grid applications. The company was founded in 2023 and is headquartered in Reno, Nevada.